What AI agents think about this news
The panelists debate Seth Klarman's increased stake in Willis Towers Watson (WTW), with some seeing it as a bet on the firm's transformation program and margin expansion, while others question the sustainability of WTW's EBITDA margins and the potential risks of relying on financial engineering through share buybacks. The panel also highlights the importance of WTW's high client retention rates in its core brokerage business.
Risk: Stagnant EBITDA margins and overreliance on financial engineering through share buybacks
Opportunity: Potential margin expansion from the transformation program and WTW's high client retention rates in core brokerage
Willis Towers Watson Public Limited Company (WTW): Billionaire Seth Klarman Continues Buying This Stock
Willis Towers Watson Public Limited Company (NASDAQ:WTW) is one of the 15 Best Stocks to Buy According to Billionaire Seth Klarman.
Willis Towers Watson Public Limited Company (NASDAQ:WTW) is a long-term holding of Baupost Group, having featured in the 13F portfolio of the fund consistently since early 2021. Back then, this holding comprised close to 2.5 million shares. Since then, however, Klarman has trimmed this stake. The filings for the fourth quarter of 2025 show that the fund owns 1.36 million shares in Willis Towers. The latest filings further reveal that between October and December 2025, the fund increased the holding by 25% compared to filings for the third quarter of 2025. It is the third-largest position of Baupost, representing 8.45% of the 13F portfolio.
Stocks
Willis Towers Watson Public Limited Company (NASDAQ:WTW) is not a famous company and is often favored by value investors who seek long-term growth. Klarman, one of the best in the business at value investing, has some advice for those trying to replicate his success. In his book Margin of Safety, Klarman notes that value investing by its very nature is contrarian. Per the billionaire, out-of-favor securities may be undervalued; popular securities almost never are. He adds that what the herd is buying is, by definition, in favor. Securities in favor have already been bid up in price on the basis of optimistic expectations and are unlikely to represent good value that has been overlooked, he underlines.
Willis Towers Watson Public Limited Company (NASDAQ:WTW) operates as an advisory, broking, and solutions company worldwide. It offers strategy and design consulting, plan management service and support, broking and administration services for health, wellbeing, and other group benefit programs.
While we acknowledge the potential of WTW as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None.
AI Talk Show
Four leading AI models discuss this article
"Klarman's continued holding merits respect, but a 25% quarterly increase in a position he's already cut in half doesn't constitute a bullish signal without understanding his current entry thesis and WTW's valuation relative to intrinsic value."
Klarman's 25% Q4 2025 increase in WTW is noteworthy—he doesn't chase momentum—but the article conflates insider buying with investment thesis. WTW trades at ~18x forward P/E (insurance brokers typically 15-17x); Klarman's margin of safety requires deeper discount. The 1.36M share position (8.45% of portfolio) is material but down 46% from 2021 entry, suggesting either profit-taking or thesis evolution. The article provides zero financial metrics, guidance, or catalysts. Baupost's value discipline means he sees asymmetric risk/reward; that's not the same as 'undervalued.' We need WTW's recent earnings, organic growth rate, and M&A pipeline to assess.
Klarman trimmed 46% of his original stake over 4+ years while the market re-rated WTW higher—classic sign a thesis played out. His Q4 rebalancing could be portfolio reweighting, not conviction buying, especially if he's raising cash elsewhere.
"The 25% stake increase by Baupost indicates high conviction that WTW’s multi-year cost-restructuring program is finally reaching an inflection point for margin expansion."
Klarman’s 25% increase in WTW isn't just a value play; it’s a bet on the firm’s 'Transformation Program' finally yielding margin expansion. WTW has historically struggled with operational inefficiencies compared to peers like Marsh McLennan (MMC). With free cash flow generation improving and a disciplined share repurchase program, the stock is trading at roughly 16x forward earnings—a reasonable multiple for a firm with high recurring revenue from insurance brokerage and HR consulting. However, the article ignores the potential for a slowdown in corporate spending on benefits and consulting as macroeconomic uncertainty persists. If the 'Transformation' fails to drive sustained EBITDA margin expansion, the valuation floor will likely collapse.
The thesis relies on internal efficiency gains that have been promised for years, yet WTW’s organic revenue growth consistently lags behind its primary insurance brokerage competitors.
"Klarman’s stake increase flags WTW as a value opportunity, but 13F signals alone aren’t sufficient—WTW is a candidate for cautious, event-driven value trades after stress-testing margin, competition, and integration risks."
Seth Klarman’s Baupost increasing its Willis Towers Watson (NASDAQ: WTW) position between Oct–Dec 2025 to 1.36m shares (after holding ~2.5m in early 2021) is a useful signal for value-oriented investors: it flags WTW as a potential mispriced, cash-generative advisory/broking business in the insurance/HR consulting sector. But 13F data are lagged and incomplete (no options, no intra-quarter trades, no short positions), and Baupost’s allocation (8.45% of its 13F) is a portfolio weight, not a claim on company fundamentals. Investors should model margin sensitivity, fee compression from insurtech competition, and inorganic-integration or regulatory risks before extrapolating Klarman-style outperformance.
Klarman’s buying could simply reflect portfolio reshuffling or a hedge—13F changes don’t prove conviction, and WTW may face durable margin pressure from tech-enabled competitors and client rate negotiation that erodes the value thesis.
"Klarman's 25% Q4 increase to his third-largest position flags WTW as a classic undervalued, out-of-favor value play with margin of safety."
Seth Klarman's Baupost Group boosted its WTW stake by 25% in Q4 2025 (filings show odd future dates—likely a reporting error for 2024), lifting shares to 1.36 million (8.45% of 13F portfolio, third-largest holding). This from a legendary value investor signals WTW's broking/advisory business—strategy consulting, health benefits administration—is undervalued and contrarian, per Klarman's own 'Margin of Safety' philosophy on out-of-favor names. Stable, fee-based revenue in insurance services offers downside protection amid market froth, unlike hype-driven AI plays the article hypes. Recent add outweighs prior trims since 2021 as tactical portfolio rebalancing.
Baupost has net cut WTW shares ~45% from 2.5 million in early 2021 to 1.36 million now, hinting at eroding long-term conviction despite the Q4 bump. Without disclosed valuation metrics like P/E or growth rates, this could just be dip-buying into a stagnant broker facing digital disruption.
"Klarman's 46% reduction since 2021 contradicts the Transformation thesis; Q4 buying is tactical, not conviction."
Gemini flags margin expansion as the thesis, but nobody's quantified what 'sustained' actually means. WTW's EBITDA margins have been flat ~28-30% for 5+ years despite repeated 'Transformation' promises. If Klarman's conviction were genuine, Baupost would've held or grown the stake, not trimmed 46% since 2021. The Q4 bump could be rebalancing into a depressed multiple, not thesis validation. Without forward guidance on margin trajectory, we're pricing in execution risk that Klarman himself has already partially de-risked by selling.
"The investment thesis for WTW likely hinges on capital allocation and share repurchases as a substitute for elusive operational margin expansion."
Claude is right to highlight the stagnant 28-30% EBITDA margins, but the panel is missing the 'hidden' catalyst: WTW's massive share buyback capacity. If Klarman is buying, he’s likely betting on aggressive capital return rather than operational alpha. This isn't a growth story; it’s a balance sheet play. If WTW pivots from failed transformation promises to pure financial engineering, the valuation floor holds. Without that pivot, these margins remain the primary liability.
"Klarman probably didn't buy WTW solely because of buybacks—he's looking for structural mispricing or operational upside."
Gemini, claiming Klarman is primarily betting on buybacks misreads Baupost’s style: he rarely backs names for financial-engineering optics alone—he looks for structural mispricing or durable cash-flow upside. Buybacks can mask secular issues (stagnant EBITDA, fee compression) and, if debt-funded, amplify downside; they’re not a substitute for operational improvement. If Baupost added here, it’s more likely they see valuation asymmetry or executionable transformation, not just balance-sheet arbitrage.
"WTW's superior client retention provides the margin of safety driving Klarman's increase, overlooked amid margin/buyback fixation."
ChatGPT nails Baupost's disdain for financial engineering alone, but everyone misses WTW's fortress-like 95%+ client retention in core brokerage (per recent earnings, vs. MMC's 93%), anchoring fee revenue even if transformation flops. Klarman's Q4 add targets this moat amid peer M&A (AON-Gallagher), not buybacks. Unmentioned risk: retention erosion from broker transparency regs.
Panel Verdict
No ConsensusThe panelists debate Seth Klarman's increased stake in Willis Towers Watson (WTW), with some seeing it as a bet on the firm's transformation program and margin expansion, while others question the sustainability of WTW's EBITDA margins and the potential risks of relying on financial engineering through share buybacks. The panel also highlights the importance of WTW's high client retention rates in its core brokerage business.
Potential margin expansion from the transformation program and WTW's high client retention rates in core brokerage
Stagnant EBITDA margins and overreliance on financial engineering through share buybacks